Comments
Loading...
Elutia (NASDAQ:ELUT) Stock Quotes, Forecast and News Summary
Elutia Stock (NASDAQ: ELUT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Elutia (ELUT) stock?
You can purchase shares of Elutia (NASDAQ:ELUT) through any online brokerage.
Who are Elutia (ELUT) competitors?
Other companies in Elutia’s space includes: Invizyne Technologies (NASDAQ:IZTC), Innate Pharma (NASDAQ:IPHA), Skye Bioscience (NASDAQ:SKYE), Adverum Biotechnologies (NASDAQ:ADVM) and Atossa Therapeutics (NASDAQ:ATOS).
What is the forecast, or price target, for Elutia (ELUT) stock?
Elutia has a consensus price target of $10.00.
What is the current price for Elutia (ELUT)?
The stock price for Elutia (NASDAQ: ELUT) is $4.07 last updated November 25, 2024 at 11:42 AM EST.
Does Elutia (ELUT) pay a dividend?
There are no upcoming dividends for Elutia.
When is Elutia (NASDAQ:ELUT) reporting earnings?
Elutia’s Q3 earnings are confirmed for Thursday, November 14, 2024.
Is Elutia (ELUT) going to split?
There is no upcoming split for Elutia.
What sector and industry does Elutia (ELUT) operate in?
Elutia is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.